Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00817310 · ClinicalTrials.gov registry record

Neurophysiology and Anatomy of Severe Intraventricular Hemorrhage (IVH)

A clinical trial of Prematurity and Intracranial Hemorrhages, sponsored by Vanderbilt University.

Completed
Registry status
60
Enrollment target
1
Study location

NCT00817310 is a study of Prematurity and Intracranial Hemorrhages that has completed, run by Vanderbilt University. The registered enrollment target is 60 participants, below the 208-participant average among 21 other Prematurity trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00817310, a study of Prematurity and Intracranial Hemorrhages, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
60 participants
Enrollment target
1
Study location

Study Summary

Currently, when premature infants develop severe intraventricular hemorrhage (IVH), a type of intracerebral bleed, there are no proven therapeutic interventions to prevent the devastating consequences of this event. These children will be likely to develop cerebral palsy or severe cognitive delays. The purpose of our study is to characterize differences in brain physiology, imaging, and function between premature infants with severe IVH and controls. The goals for gathering this information are to generate baseline data, which could facilitate early screening for complications of IVH in premature infants. These baseline data would also allow the design and implementation of early therapeutic interventions to help rehabilitate premature infants with severe IVH.

Study Locations (1)

Tennessee

  • Monroe Carell Children's Hospital at Vanderbilt, NICU - Nashville

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2009-01
Est. Completion 2011-06

Sponsor

Vanderbilt University

430 total trials

What the Registry Record Tells You About NCT00817310

The ClinicalTrials.gov registry entry for NCT00817310 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 208-participant average among 21 other Prematurity trials with a reported enrollment target (71% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Prematurity appearing as the primary indexed condition, and to 0 interventions.

NCT00817310 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00817310 about?

NCT00817310 is a clinical study titled "Neurophysiology and Anatomy of Severe Intraventricular Hemorrhage (IVH)". Currently, when premature infants develop severe intraventricular hemorrhage (IVH), a type of intracerebral bleed, there are no proven therapeutic interventions to prevent the devastating consequences of this event. These children will be likely to develop cerebral palsy or severe cognitive delays. ...

What is the current status of trial NCT00817310?

This trial is currently completed. The enrollment target is 60 participants. The study started on 2009-01. Estimated completion is 2011-06.

What conditions does trial NCT00817310 study?

This clinical trial studies the following conditions: Prematurity, Intracranial Hemorrhages.

Who is sponsoring clinical trial NCT00817310?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00817310 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prematurity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.